Key result
CMR detects myocardial fibrofatty infiltration in ~75% of DE50-MD dogs, validating the preclinical DMD model.
Why the study?
Cardiomyopathy is an expected consequence of Duchenne muscular dystrophy with variable onset and progression, warranting characterization of myocardial pathology in the clinically relevant DE50-MD canine model using cardiac magnetic resonance imaging.
Does cardiac magnetic resonance imaging accurately identify myocardial abnormalities in the DE50-MD dog model of Duchenne Muscular Dystrophy?
Does cardiac magnetic resonance imaging accurately identify myocardial abnormalities in the DE50-MD dog model of Duchenne Muscular Dystrophy?
CMR with LGE and parametric mapping accurately identifies progressive myocardial abnormalities in the DE50-MD dog model, validating its relevance as a preclinical model for DMD cardiomyopathy.
Supports DE50-MD dogs for DMD cardiomyopathy studies; leaves translation to humans open pending further validation.
Cardiomyopathy is an expected consequence of the invariably fatal, X-linked muscle-wasting disease, Duchenne Muscular Dystrophy, (DMD) but onset and progression vary between individuals. Cardiac magnetic resonance imaging (CMR) is invaluable for identification of subclinical myocardial abnormalities, to stratify disease and to identify patients needing early therapeutic intervention. The dystrophin-deficient DE50-MD canine model harbours a mutation in the major hot spot region for mutations in DMD patients and mimics the preclinical cardiac and skeletal muscle of DMD boys. We performed serial parametric (T1, T2 and extracellular volume) mapping and late gadolinium enhancement (LGE) studies to characterise myocardial pathology in 15-to-36-month-old DE50-MD, (n=8) and wild type (WT, n=6) dogs. In 6/8 DE50-MD dogs left ventricular (LV) subepicardial LGE identified myocardial fibrofatty infiltration, (confirmed with histopathology post-mortem) with the characteristic distribution reported in DMD cardiomyopathy. Parametric mapping techniques exposed diffuse myocardial pathology that was most pronounced in DE50-MD dogs of 30 months and older and supported extracellular matrix expansion due to fibrosis, with or without regional myocardial oedema and /or fatty infiltration in individual dogs. All CMR markers of fibrosis worsened with age in DE50-MD dogs and paralleled deterioration in ventricular function evaluated with conventional and speckle tracking (circumferential strain) echocardiography, the burden of fragmented QRS complexes in 12-lead electrocardiography studies and the severity of pathological lesions. LGE and parametric mapping studies accurately identified a spectrum of myocardial abnormalities encountered in young DE50-MD dogs, further validating the relevance of these dogs as a preclinical model of DMD cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Sargent et al. (2025) studied Duchenne Muscular Dystrophy cardiomyopathy (n=14). Cardiac magnetic resonance imaging (parametric mapping and LGE) vs. Wild type dogs was evaluated on Myocardial fibrofatty infiltration identified by left ventricular subepicardial LGE. Cardiac magnetic resonance imaging identified myocardial fibrofatty infiltration in 75% (6/8) of DE50-MD dogs, validating the relevance of these dogs as a preclinical model of DMD cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: